Notice of interim decisions on proposed amendments to the Poisons Standard - ACMS #37 ACCS #33 Joint ACMS-ACCS #30 - March 2022

This web publication constitutes a notice for the purposes of regulation 42ZCZP of the Therapeutic Goods Regulations 1990 (the Regulations). In accordance with regulation 42ZCZP, this notice sets out:

• the interim decisions made by a delegate of the Secretary under regulation 42ZCZN in relation to proposed amendments to the current Poisons Standard which were referred to an expert advisory committee under subdivision 3D.2 of the Regulations in March 2022;
• the proposed date of effect of the proposed amendments (in circumstances where the interim decision proposes an amendment to the current Poisons Standard).

In accordance with regulation 42ZCZP, interested persons (including the applicant requesting the amendment) are invited to make submissions to the Secretary in relation to these interim decisions on or before 15 September 2022.

Please note that in accordance with subregulation 42ZCZQ(4) of the Regulations, the Secretary must publish all relevant submissions received, unless the Secretary considers the information to be confidential information.

If you have difficulty accessing the consultation hub or uploading your submission, contact medicines.scheduling@health.gov.au and include 'Proposed Amendments to the Poisons Standard (Medicines)' or 'Proposed Amendments to the Poisons Standard (Chemicals)' in the subject line of the email.

Interim decision

• Notice of interim decisions on proposed amendments to the Poisons Standard - ACMS#37, Joint ACMS-ACCS#30, ACCS #33 meetings, March 2022 (pdf, 440KB)
• Notice of interim decisions on proposed amendments to the Poisons Standard –ACMS#37, Joint ACMS-ACCS#30, ACCS #33 meetings March 2022 (docx, 261KB)

Contents

• 1 Notice of interim decisions on made under Regulation 42ZCZN of the Therapeutic Goods Regulations 1990
• 2 Interim decisions on proposed amendments referred to the Advisory Committee on Medicines Scheduling (ACMS meeting #37, March 2022)
  • 2.1 Interim decision in relation to azelastine and fluticasone propionate
• 3 Interim decisions on proposed amendments referred to the Advisory Committee on Medicines and Chemicals Scheduling in joint session (Joint ACMS-ACCS meeting #30, March 2022)
  • 3.1 Interim decision in relation to cannabis and tetrahydrocannabinols
  • 3.2 Interim decision in relation to lead
  • 3.3 Interim decision in relation to meloxicam
  • 3.4 Interim decision in relation to lidocaine
• 4 Interim decisions on proposed amendments referred to the Advisory Committee on Chemicals Scheduling (ACCS meeting #33, March 2022)
  • 4.1 Interim decision in relation to flumioxazin